Gingival enlargement (GE) remains a significant concern for dental and medical clinicians in India. Therefore, effective gingival enlargement management requires identifying specific risk factors and drug-induced triggers early in the diagnostic process. Specifically, recent meta-analyses confirm that certain systemic medications significantly increase the risk of gingival tissue overgrowth. Patients using phenytoin, calcium-channel blockers (CCBs), and cyclosporine A (CsA) show the highest incidence rates. For instance, individuals on CCBs experience more severe enlargement than patients on other antihypertensive classes. Similarly, cyclosporine users face a significantly higher risk compared to those taking tacrolimus. Furthermore, fixed orthodontic treatments and poor oral hygiene consistently exacerbate the condition by promoting plaque retention.

Effective Gingival Enlargement Management Strategies

Clinicians must prioritize professional mechanical plaque removal (PMPR) to treat this condition effectively. Because biofilm accumulation drives localized inflammation, oral hygiene instructions (OHIs) are essential for all patients starting high-risk medications. Moreover, systemic azithromycin serves as a valid adjunctive treatment for severe or recurrent cases. Alternatively, physicians may consider changing the offending medication to a safer alternative to reduce symptoms. Consequently, combining local hygiene protocols with systemic drug adjustments offers the best prognosis for long-term recovery. Furthermore, regular clinical monitoring helps prevent recurrence in high-risk pediatric and adult patients.

What are the primary risk factors for gum enlargement?

The primary risk factors include the chronic use of phenytoin, calcium-channel blockers, or cyclosporine A, alongside fixed orthodontic appliances and poor oral hygiene.

Is surgery always necessary for gingival enlargement management?

No, many cases respond well to non-surgical professional plaque removal and improved home care protocols. However, specialists may recommend surgical intervention for severe cases that interfere with speech or mastication.

Disclaimer: This content is for informational and educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

• Nibali L et al. Risk Factors and Management of Gingival Enlargement: A Systematic Review and Meta-Analysis. J Clin Periodontol. 2026 Jun 08. doi: 10.1111/jcpe.70125. PMID: 42260319.


• Bharti V, Bansal C. Drug-induced gingival overgrowth: The nemesis of gingiva unravelled. J Indian Soc Periodontol. 2013;17(2):182-187.


• Tamchos R, et al. Nonsurgical Management of Drug-induced Gingival Enlargement in a Young Adolescent with Chronic Kidney Disease: A Case Report. Int J Clin Pediatr Dent. 2025;18(9):1164-1167.